Table 2.
Patient HLA | Donor HLA | Lymph node HLA | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lymph node | A | A | B | B | Bw | Bw | A | A | B | B | Bw | Bw | A | A | A | B | B | B | Bw | Bw |
LN 1.3 | 3 | 28 | 44 | 35 | 4 | 6 | 1 | 24 | 13 | 44 | 4 | – | 1 | 3 | 28 | 44 | 35 | – | 4 | 6 |
LN 2.4 | 1 | 2 | 14 | w60 | 6 | – | 2 | 3 | 27 | 35 | 4 | 6 | 2 | 3 | – | 27 | 35 | w60 | 4 | 6 |
LN 3.5 | 1 | 24 | 35 | w55 | 6 | – | 29 | 31 | 7 | w60 | 6 | – | 1 | 24 | 31 | 35 | w60 | w55 | 6 | – |
LN 4.9 | 2 | – | w62 | 35 | 6 | – | 26 | 11 | 18 | w41 | 6 | – | 2 | 11 | – | w62 | 35 | 18 | 6 | – |
LN 5.17 | 2 | 28 | 27 | w60 | 4 | 6 | 2 | 28 | 44 | w57 | 4 | – | 2 | 28 | – | 27 | w60 | 44 | 4 | 6 |
LN 6.19 | 2 | – | 35 | – | 6 | – | 25 | 32 | 18 | w60 | 4 | 6 | 2 | 25 | – | 35 | – | – | 4 | 6 |
LN 7.59 | 2 | w33 | 44 | 38 | 4 | – | 2 | 29 | 7 | – | 6 | – | ND | ND | ND | ND | ND | ND | ND | ND |
LN 8.79 | 2 | 24 | 8 | 35 | 6 | – | 2 | 28 | 44 | 35 | 4 | 6 | 2 | 24 | 28 | 8 | 35 | – | 4 | 6 |
LN 9.693 | 1 | – | w57 | – | 4 | – | 3 | 29 | 7 | 44 | 4 | 6 | 1 | – | – | w57 | – | – | 4 | – |
LN 10.755 | 2 | – | 51 | 35 | 6 | – | 3 | 11 | 7 | w48 | 6 | – | ND | ND | ND | ND | ND | ND | ND | ND |
Denotes HLA antigen reactions by microlymphocytotoxicity assays.